Amarantus Buys Power3's IP Portfolio for $40K | GenomeWeb

NEW YORK (GenomeWeb News) – Amarantus BioScience today announced it has acquired all the intellectual property assets from Power3 Medical Products for $40,000.

Based in The Woodlands, Texas, Power3 filed for Chapter 7 bankruptcy earlier this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.